CRISPR Gene Enhancing Takes Subsequent Step in TTR Amyloidosis
Therapy with the investigational CRISPR-Cas9 gene-editing remedy, NTLA-2001, led to fast responses in sufferers with transthyretin (TTR) amyloidosis with cardiomyopathy ...
Tag: TTR
